March 18, 2025 - 13:47

As Wall Street grapples with the recent fluctuations in stock prices, futures for the Dow, S&P 500, and Nasdaq experienced a decline following a two-day rally. Investors are now questioning whether the recent sell-off signifies a potential bottom for the stock market. This uncertainty comes at a crucial time as the Federal Reserve prepares to hold its upcoming policy meeting, where key decisions regarding interest rates and economic outlook will be discussed.
Market analysts are closely monitoring the situation, weighing the implications of the Fed's actions on future market performance. The recent rally had sparked hopes for a rebound, but the current pullback raises concerns about the sustainability of such gains. As the meeting approaches, traders are likely to remain cautious, evaluating economic indicators and comments from Fed officials for clues on the central bank's future direction. The outcome of this meeting could significantly impact investor sentiment and market trends in the coming weeks.
June 8, 2026 - 22:27
What history tells us about Marvell's upcoming S&P 500 inclusionMarvell Technology shares have been climbing sharply after the announcement that the company will join the S&P 500 index on June 22. Investors are betting that the move will bring fresh demand from...
June 8, 2026 - 04:51
Is PDD Holdings Inc. (PDD) A Good Stock To Buy Now?A recent discussion on a value investing forum laid out a bullish case for PDD Holdings Inc., the parent company of e-commerce platforms Temu and Pinduoduo. As of late May, shares were trading near...
June 7, 2026 - 03:13
Apple Stock: Buy, Sell, or Hold?Apple`s stock is trading close to an all-time high, and a series of potential catalysts could sustain the upward momentum. The company continues to benefit from strong demand for its latest iPhone...
June 6, 2026 - 22:38
Eli Lilly's $3.8 Billion Vaccine Bets: Here's the Big Story Many Investors Are MissingEli Lilly is making a serious push into the vaccine business. The pharmaceutical giant announced a trio of acquisitions totaling $3.8 billion, aimed at building a new division focused on infectious...